Recursion Pharmaceuticals Inc

Business

The outlook and analysis of Recursion Pharmaceuticals Inc (RXRX)’s stock

Ulysses Smith

At the time of writing, Recursion Pharmaceuticals Inc [RXRX] stock is trading at $5.89, up 6.51%. In order to assess ...

Business

The outlook and analysis of Recursion Pharmaceuticals Inc (RXRX)’s stock

Ulysses Smith

At the time of writing, Recursion Pharmaceuticals Inc [RXRX] stock is trading at $5.53, up 0.73%. In order to assess ...

MZP News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.